Ignite Creation Date:
2025-12-24 @ 1:14 PM
Ignite Modification Date:
2025-12-27 @ 9:56 PM
Study NCT ID:
NCT03673995
Status:
COMPLETED
Last Update Posted:
2020-06-16
First Post:
2018-08-22
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Myoinositol Plus L-tyrosine, Selenium and Chromium in PCOS
Sponsor:
Pharmarte srl
Organization:
Study Overview
Official Title:
Use of Myoinositol Plus L-tyrosine, Selenium and Chromium in PCOS Women
Status:
COMPLETED
Status Verified Date:
2018-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
PCOS patients were treated every day, with one sachet containing 2000 mg myo-inositol, 500 mg L-tyrosine, 40 mcg chromium picolinate, 55 mcg selenium, 200 mcg folic acid. All patients underwent, before starting the therapy, after 3 months and 6 months, hormonal evaluation , hirsutism scoring and ovulation assesment. Most of them during the treatment improved their symptoms.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: